Lupus & antiphospholipid syndrome
Associations of Postdischarge Follow‐Up With Acute Care and Mortality in Lupus: A Medicare Cohort Study
Authors' conclusion
One-third of lupus hospitalizations lacked follow-up, with significant disparities in rural and disadvantaged neighborhoods. Follow-up was associated with increased acute care, but 65% lower mortality in older systemic lupus erythematosus patients.
Study context
- Population
- Medicare adults with lupus-coded hospitalizations, January-November 2014, discharged home without hospice, with continuous Medicare A/B coveragehospitalizations
- Exposure
- Timely postdischarge follow-up vs no follow-up
- Outcome
- Acute care use (readmission, observation stay or ED visit) and mortality
- Follow-up
- 30 days
Methodological details20% random sample of Medicare adults, survival analysis adjusted for sociodemographic information and comorbidities
- 20% random sample of Medicare adults
- Survival analysis adjusted for sociodemographic information and comorbidities
Main finding
As reported in the abstract
Follow-up vs No follow-upEstimate (95% CI)
27% higher hazard
aHR (acute care use) 1.27(1.09–1.47)
65% lower mortality
aHR (mortality) 0.35(0.19–0.67)
Observational data: associations, not effects.
Further findings
Lupus hospitalizations lacking 30-day follow-up
- Hospitalizations lacking 30-day follow-up
- 35%
- Younger age, disadvantaged neighborhoods and rurality associated with lower odds of follow-up
Original publication
Associations of Postdischarge Follow‐Up With Acute Care and Mortality in Lupus: A Medicare Cohort Study. Arthritis Care Res (Hoboken). Published 8 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →